Samsung Pharm (001360) — Free Cash Flow Generation Index
Latest as of June 2022:
0.60x
Samsung Pharm (001360) has a Free Cash Flow Generation Index of 0.60x as of June 2022. Free cash flow of ₩952.48 Million represents 1% of operating cash flow (₩1.59 Billion). Read Samsung Pharm balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
0.60x
Free Cash Flow / Operating CF
Free Cash Flow
₩952.48 Million
KRW
Operating Cash Flow
₩1.59 Billion
KRW
Capital Expenditures
₩638.30 Million
KRW
Samsung Pharm Free Cash Flow Generation Index (2017–2017)
Historical FCF Generation Index trend for Samsung Pharm across 1 annual periods. Explore Samsung Pharm capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Samsung Pharm (2017–2017)
Year-by-year Free Cash Flow Generation Index for Samsung Pharm. For the full company profile including market capitalisation, see 001360 market cap.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2017 | -0.16x | ₩-847.92 Million | ₩5.15 Billion | ₩6.11 Billion | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).